4//SEC Filing
Patel Ronil A. 4
Accession 0001140361-23-056374
CIK 0001228627other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:30 PM ET
Size
7.1 KB
Accession
0001140361-23-056374
Insider Transaction Report
Form 4
Patel Ronil A.
Chief Business Officer
Transactions
- Award
Common Stock
2023-12-01+49,692→ 91,996 total - Award
Employee Stock Option (right to buy)
2023-12-01+74,538→ 74,538 totalExercise: $2.99Exp: 2033-11-30→ Common Stock (74,538 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units which vest with respect to 25% on the six month anniversary of the grant date, with the remaining shares vesting in equal installments every six months thereafter over the two years following the grant date, subject to continuing service.
- [F2]The option will vest with respect to 25% on the six month anniversary of the grant date, with the remaining shares vesting in equal installments every six months thereafter over the two years following the grant date, subject to continuing service.
Documents
Issuer
Ocuphire Pharma, Inc.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001974660
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 4:30 PM ET
- Size
- 7.1 KB